Last 12 months
Inside the activity.
0 purchase rows · 21 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 09, 2021 Filed Nov 11, 2021 00:07 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063971 · doc4.xml · nonDerivative · entry 8 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 652,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F5 · ownership.nature: The reported securities are held directly by the Shani Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 09, 2021 Filed Nov 11, 2021 00:07 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063971 · doc4.xml · nonDerivative · entry 7 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 652,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · ownership.nature: The reported securities are held directly by the Noam Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 09, 2021 Filed Nov 11, 2021 00:07 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063971 · doc4.xml · nonDerivative · entry 6 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 652,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F3 · ownership.nature: The reported securities are held directly by the Adi Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 09, 2021 Filed Nov 11, 2021 00:07 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 55,000 | $25.00 | $1,375,000.00 |
DisclosureSEC source: 0001209191-21-063971 · doc4.xml · nonDerivative · entry 5 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,082,875 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| November 08, 2021 Filed Nov 11, 2021 00:07 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063971 · doc4.xml · nonDerivative · entry 4 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 667,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F5 · ownership.nature: The reported securities are held directly by the Shani Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 08, 2021 Filed Nov 11, 2021 00:07 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063971 · doc4.xml · nonDerivative · entry 3 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 667,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · ownership.nature: The reported securities are held directly by the Noam Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 08, 2021 Filed Nov 11, 2021 00:07 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063971 · doc4.xml · nonDerivative · entry 2 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 667,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F3 · ownership.nature: The reported securities are held directly by the Adi Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 08, 2021 Filed Nov 11, 2021 00:07 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 55,000 | $25.00 | $1,375,000.00 |
DisclosureSEC source: 0001209191-21-063971 · doc4.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,137,875 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 23:39 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063451 · doc4.xml · nonDerivative · entry 8 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 682,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F5 · ownership.nature: The reported securities are held directly by the Shani Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 23:39 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063451 · doc4.xml · nonDerivative · entry 7 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 682,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · ownership.nature: The reported securities are held directly by the Noam Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 23:39 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063451 · doc4.xml · nonDerivative · entry 6 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 682,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F3 · ownership.nature: The reported securities are held directly by the Adi Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 23:39 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 55,000 | $25.00 | $1,375,000.00 |
DisclosureSEC source: 0001209191-21-063451 · doc4.xml · nonDerivative · entry 5 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,192,875 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 23:39 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063451 · doc4.xml · nonDerivative · entry 4 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 697,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F5 · ownership.nature: The reported securities are held directly by the Shani Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 23:39 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063451 · doc4.xml · nonDerivative · entry 3 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 697,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · ownership.nature: The reported securities are held directly by the Noam Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 23:39 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001209191-21-063451 · doc4.xml · nonDerivative · entry 2 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 697,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F3 · ownership.nature: The reported securities are held directly by the Adi Rosenthal 2007 Trust dated March 27, 2007, for which the Reporting Person serves as trustee. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 23:39 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 55,000 | $25.00 | $1,375,000.00 |
DisclosureSEC source: 0001209191-21-063451 · doc4.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,247,875 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 22:53 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 417,213 | $0.00 Strike: $23.70 | $0.00 |
DisclosureSEC source: 0001209191-21-059144 · doc4.xml · derivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,213 Underlying: Common Stock · 417,213 shares Expires 2031-10-01 F1 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on November 1, 2021. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 18:57 UTC |
King RobertChief Development Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 35,635 | $0.00 Strike: $23.70 | $0.00 |
DisclosureSEC source: 0001209191-21-059148 · doc4.xml · derivative · entry 2 King Robert · CIK 0001635264 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,635 Underlying: Common Stock · 35,635 shares Expires 2031-10-01 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on November 1, 2021. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 18:57 UTC |
King RobertChief Development Officer
|
GrantCommon Stock | 7,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059148 · doc4.xml · nonDerivative · entry 1 King Robert · CIK 0001635264 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,284 F1 · shares: The shares are represented by restricted stock units which vest in 12 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| October 01, 2021 Filed Oct 8, 2021 16:06 UTC Amendment |
King RobertChief Development Officer
|
GrantCommon Stock | 5,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060030 · doc4a.xml · nonDerivative · entry 1 King Robert · CIK 0001635264 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,256 F1 · shares: The shares are represented by restricted stock units which vest in 12 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| September 23, 2021 Filed Sep 24, 2021 01:12 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 9,625 | $25.10 | $241,567.29 |
DisclosureSEC source: 0001209191-21-057519 · doc4.xml · nonDerivative · entry 3 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,302,875 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.26, inclusive. F3 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| September 23, 2021 Filed Sep 28, 2021 00:00 UTC |
GAROFALO ELIZABETH A.Director
|
GrantStock Option (right to buy) · Derivative | 33,235 | $0.00 Strike: $24.26 | $0.00 |
DisclosureSEC source: 0001209191-21-057851 · doc4.xml · derivative · entry 1 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,235 Underlying: Common Stock · 33,235 shares Expires 2031-09-23 F1 · derivative.exercise_date: One-fourth of the shares subject to the option vest on September 23, 2022 and 1/48th of the shares vest monthly thereafter. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 01:12 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 5,283 | $26.10 | $137,890.00 |
DisclosureSEC source: 0001209191-21-057519 · doc4.xml · nonDerivative · entry 2 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,312,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.22, inclusive. F3 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 01:12 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 94,717 | $25.29 | $2,395,298.21 |
DisclosureSEC source: 0001209191-21-057519 · doc4.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,317,783 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4. F3 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:54 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 8,462 | $26.56 | $224,738.87 |
DisclosureSEC source: 0001209191-21-057273 · doc4.xml · nonDerivative · entry 4 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,412,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $26.64, inclusive. F3 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:54 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 91,538 | $26.07 | $2,386,697.74 |
DisclosureSEC source: 0001209191-21-057273 · doc4.xml · nonDerivative · entry 3 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,420,962 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $26.49, inclusive. F3 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:54 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 8,046 | $26.33 | $211,848.77 |
DisclosureSEC source: 0001209191-21-057273 · doc4.xml · nonDerivative · entry 2 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,512,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.28 to $26.43, inclusive. F3 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:54 UTC |
Rosenthal ArnonDirector · Chief Executive Officer
|
SaleCommon Stock | 91,954 | $25.76 | $2,368,541.94 |
DisclosureSEC source: 0001209191-21-057273 · doc4.xml · nonDerivative · entry 1 Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,520,546 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.25 to $26.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) through (6) to this Form 4. F3 · ownership.nature: The reported securities are held directly by The Rosenthal Family Revocable Trust Dated November 4, 1994, as restated on June 9, 1999, for which the Reporting Person serves as trustee. Read SEC document |
| September 10, 2021 Filed Feb 1, 2023 00:17 UTC |
Yaffe KristineDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $18.10 | $0.00 |
DisclosureSEC source: 0001209191-23-005810 · doc4.xml · derivative · entry 2 Yaffe Kristine · CIK 0001783895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 2,000 shares Expires 2029-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-fourth of the shares subject to the option vested on August 9, 2020 and an additional 1/48th of the shares vest monthly thereafter. Read SEC document |
| September 10, 2021 Filed Feb 1, 2023 00:17 UTC |
Yaffe KristineDirector
|
Exercise / conversionCommon Stock | 2,000 | $18.10 | $36,200.00 |
DisclosureSEC source: 0001209191-23-005810 · doc4.xml · nonDerivative · entry 1 Yaffe Kristine · CIK 0001783895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of the filing date, the amount of securities beneficially owned by the reporting person is 11,459 shares. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,525 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · derivative · entry 8 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,450 Underlying: Common Stock · 4,525 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,734 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · derivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 8,734 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,691 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · derivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,000 Underlying: Common Stock · 9,691 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 300 | $27.79 | $8,337.00 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,319 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.71 to $27.83, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 22,650 | $27.17 | $615,429.95 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,619 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 4,525 | $17.15 | $77,603.75 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 8,734 | $10.14 | $88,562.76 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 9,691 | $8.16 | $79,078.56 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 22:13 UTC |
SCHELLER RICHARD HDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 56,260 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-050471 · doc4.xml · derivative · entry 5 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,574 Underlying: Common Stock · 56,260 shares Expires 2028-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on November 22, 2018. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 22:13 UTC |
SCHELLER RICHARD HDirector
|
SaleCommon Stock | 3,392 | $28.30 | $96,001.06 |
DisclosureSEC source: 0001209191-21-050471 · doc4.xml · nonDerivative · entry 4 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.23 to $28.48, inclusive. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 22:13 UTC |
SCHELLER RICHARD HDirector
|
SaleCommon Stock | 52,868 | $27.64 | $1,461,340.25 |
DisclosureSEC source: 0001209191-21-050471 · doc4.xml · nonDerivative · entry 3 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,392 F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $27.17 to $27.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 22:13 UTC |
SCHELLER RICHARD HDirector
|
Exercise / conversionCommon Stock | 56,260 | $10.14 | $570,476.40 |
DisclosureSEC source: 0001209191-21-050471 · doc4.xml · nonDerivative · entry 2 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,574 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · derivative · entry 17 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,975 Underlying: Common Stock · 10,574 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,883 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · derivative · entry 16 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,984 Underlying: Common Stock · 11,883 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,292 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · derivative · entry 15 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,691 Underlying: Common Stock · 7,292 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 17,149 | $39.32 | $674,219.79 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 13 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,319 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.95 to $39.62, inclusive. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 7,700 | $38.14 | $293,685.70 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 12 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,468 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.54, inclusive. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
SaleCommon Stock | 4,900 | $37.41 | $183,332.03 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 11 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,168 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.70 to $37.69, inclusive. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 10,574 | $17.15 | $181,344.10 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 10 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC |
Paul RobertChief Medical Officer
|
Exercise / conversionCommon Stock | 11,883 | $10.14 | $120,493.62 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 9 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.